...
首页> 外文期刊>Pfluegers Archiv: European Journal of Physiology >Action of mibefradil and lacidipine on the isolated human anterior tibial artery.
【24h】

Action of mibefradil and lacidipine on the isolated human anterior tibial artery.

机译:米贝拉地尔和拉地平对孤立的人前胫骨动脉的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

In isolated human anterior tibial artery the effects of two different types of calcium channel antagonists, mibefradil (a selective T-type Ca2+ channel antagonist) and lacidipine (a 1,4 dihydropyridine Ca2+ channel antagonist, acting at L- and T-type, but binds preferentially at L-type Ca2+ channels) were compared. Both drugs reduced the contractions of isolated arteries induced by 60 mM KCl. The potency (IC50) of mibefradil was 6.5 microM and of lacidipine 82.4 nM. The potencies of both Ca2+ channel antagonists differed significantly (p<0.001 at 0.1 and 1 microM; p<0.01 at 10 microM). Lacidipine was 79-times more effective than mibefradil in reducing the vasoconstriction in isolated human anterior tibial artery. One of the reasons for higher potency of lacidipine could be a higher density of L-type than of T-type Ca2+ channels in tissue of the human anterior tibial artery.
机译:在分离的人胫骨前动脉中,两种不同类型的钙通道拮抗剂,米贝拉地尔(选择性的T型Ca2 +通道拮抗剂)和拉地平(1,4二氢吡啶类Ca2 +通道拮抗剂,分别作用于L型和T型)的作用,但比较了优先结合在L型Ca2 +通道上的结合)。两种药物均减少了60 mM KCl诱导的孤立动脉的收缩。米贝地尔的效价(IC50)为6.5 microM,拉西地平的效价为82.4 nM。两种Ca2 +通道拮抗剂的效价均存在显着差异(0.1和1 microM时p <0.001; 10 microM时p <0.01)。拉西地平在减少孤立的人胫前动脉的血管收缩方面比米贝地尔高79倍。拉西地平效力更高的原因之一可能是人胫骨前动脉组织中L型密度高于T型Ca2 +通道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号